Ed Stacey - Profile and Investment Details

Investor Profile

Ed Stacey is a Venture Capital, Private Equity Firm based in Cambridge, England, United Kingdom with a diverse investment portfolio that includes companies such as Closed Loop Medicine, Nu Quantum, Porotech, Funderbeam, Thought Machine, Spectral Edge, Nyobolt, Neul, Myrtle Software, TurinTech, Apperio, MQube, Opteran, Venture Technologies Ltd, Oxford Space SystemsIotic, Sirigen, Privitar, AccelerComm, Pangaea Data, Stillfront Group, Rosslyn Data Technologies PLC, Cambridge GaN Devices, Grapeshot, Spikes Cavell & Co, Phonetic Arts, Divido, miiCard, Digital Assess, CyberSmart, Cambridge Communication Systems, Wluper, The ID Co., CybSafe, Speechmatics, Concirrus, Senseye, Unbound, Focal Point Positioning, causaLens, Audio Analytic, Bloomsbury AI, Synthesized, FNA, BioBeats, KisanHub, Paragraf, Focal Point Data Risk, Dataswift, Desktop Genetics, BMLL Technologies, Imandra, Fluidic Analytics, Optellum, Neurovalens, ChargePoint Services, TOffeeAM, . Over time, Ed Stacey has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ed Stacey is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Clean Tech, Health Care, Emerging Technology, Talent Management, Research and Development, Telecommunications, Cybersecurity, DeepTech, Disruptive Innovation, Wellness, Enterprise Software, Investment Management, Digital Media, Energy, Software Solutions, Strategic Partnerships, Life Science, Banking, Artificial Intelligence (AI), Robotics, Startups, Information Technology (IT), Analytics, Cloud Computing, Internet of Things (IoT), Venture Fundraising, Technology, Synthetic Biology, Finance, IoT, Automation, Software, Intellectual Property, Manufacturing, Biotechnology, Medical Devices, Entrepreneurship, Precision Medicine, Energy Tech, Innovation, Clinical Trials, Groceries, FinTech, Disruptive technology, Digital Transformation, Space Technology, Research, Data Privacy, Agriculture, Consulting, Sustainable Energy, Hardware, UK Startups, Utilities, Mergers and Acquisitions, Generative Tech/AI, Digital Health, Renewable Energy, Medical, SaaS, Battery, Information Technology, B2B, Advanced Materials, Health Tech, Machine Learning, Quantum Computing, Material Science, Pharmaceuticals, Healthcare Technology, Risk Management, Acquisitions may find it worthwhile to explore potential connections with Ed Stacey, as their portfolio suggests a familiarity and interest in this area.

Understanding Ed Stacey’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.